Zuckerberg, Gates team up to contribute $25M for research into coronavirus treatments

Facebook founder Mark Zuckerberg and his wife, Dr. Priscilla Chan, are teaming up with the Bill and Melinda Gates Foundation to donate $25 million toward research on possible coronavirus treatments.

“I’m really proud to share that [the Chan Zuckerberg Initiative is] going to be joining Gates and others to put together something they’re calling the therapeutics accelerator to fight coronavirus,” Chan told “CBS This Morning” co-host Gayle King.

Chan told King that their goal is “to fund a group to screen all the drugs that we know have potential effects against coronavirus.” 

Zuckerberg elaborated on the objective, saying that one drug can often be used to treat multiple diseases. 

“You can basically take all those drugs that have already been screened as safe and test them to see if they might also have a positive impact for either preventing the coronavirus or reducing the symptoms and making it less damaging,” he said.

To Zuckerberg’s point, New York is already testing hydroxychloroquine — a proven anti-malarial drug — with the antibiotic azithromycin to see if the combo can be an effective treatment for COVID-19. The combination proved effective in a small, controversial study in France, but there has yet to be widespread testing on the possible treatment option.

 

Tags Bill and Melinda Gates Foundation Chan Zuckerberg Initiative Coronavirus Gayle King Hydroxychloroquine Mark Zuckerberg Mark Zuckerberg Priscilla Chan

Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Regular the hill posts

Main Area Top ↴

THE HILL MORNING SHOW

More Technology News

See All
Main Area Bottom ↴

Testing Video

ASR RAW Boys Lacrosse: Coronado 8, Poway 6

ASR RAW Boys Lacrosse: Coronado 8, Poway 6
ASR RAW Girls Lacrosse: Coronado 15, Cathedral ...
Former Torrey Pines teammates take home another NCAA ...
Boys Lacrosse: Torrey Pines 11, Bishop's 9
More Videos

Most Popular

Load more